Who do you relate to more when it comes to diabetes management? An angel who follows the recommended guidelines (Jeremy/Gallant), or a stubborn hellion easily influenced by temptation (Steve/Goofus)? Check out some of these scenarios from Dr. E. and see if you are who you think you are.
[read_more text="read more" title="read more" url="https://tcoyd.org/2021/01/the-goofus-and-gallant-of-diabetes/" align="left"]
With recent news about SGLT2s and GLP-1 RAs helping to protect against heart disease in addition to their primary purpose of lowering blood sugars, Dr. Edelman addresses the question of whether it’s safe to take them together, and if they can also cause hypoglycemia.
[read_more text="read more" title="read more" url="https://tcoyd.org/2020/10/cardiovascular-benefits-of-sglt2-inhibitors-glp-1-ras/" align="left"]
Did you know that certain aspects of type 2 diabetes can change over time? Even if you’ve had years of great blood sugar control, you still may need to make some medication adjustments down the road, and that’s totally normal.
[read_more text="read more" title="read more" url="https://tcoyd.org/2020/06/dont-let-your-fear-of-the-needle-stop-you-from-taking-control/" align="left"]
Recently approved by the FDA, Ozempic sets itself apart from other once-weekly GLP-1 RAs for type 2 diabetes by demonstrating the quickest and greatest effect in reducing blood glucose and body weight in studies. Is it right for you?
[read_more text="read more" title="read more" url="https://tcoyd.org/2018/03/https-tcoyd-org-2018-03-ozempic/" align="left"]
